🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Recurrent Prostate Cancer

COAST Therapy in Advanced Solid Tumors and Prostate Cancer NCT05036226Phase 1, Phase 21 site📍 Charleston Medical University of South Carolina · Tests: Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine, Metformin, Sirolimus, Dasatanib, Hydroxychloroquine, Metf… Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer NCT05646550Phase 11 site📍 Tübingen University Hospital Tuebingen · Tests: CC-1 Infusion High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy NCT06982469n/a1 site📍 Pamplona Clinica Universidad de Navarra, Universidad de Navarra · Tests: Brachytherapy A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma NCT03460977Phase 185 sites📍 Tucson📍 Tucson📍 Tucson Pfizer · Tests: Mevrometostat (PF-06821497), Enzalutamide, Itraconazole PROCARE - PROstate Cancer Real World Evidence Registry NCT06835218n/a53 sites📍 Freiburg im Breisgau📍 Heidelberg📍 Mannheim UroTrials Company (GmbH) Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer NCT05753566Phase 22 sites📍 Nanjing📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: Rezvilutamide, Androgen deprivation therapy (ADT), SRT Focal Salvage Brachytherapy Study (FocaSaBra) NCT05715502NA1 site📍 Poznan The Greater Poland Cancer Centre · Tests: brachytherapy Detection of Minimal Residual Disease Post-prostatectomy NCT07334275n/a1 site📍 Nijmegen Radboud University Medical Center Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup]) NCT07831824Phase 2, Phase 31 site📍 Grand Rapids Lantheus Medical Imaging · Tests: [68Ga]-LNTH-2401 Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer NCT05328505NA2 sites📍 London📍 Toronto University Health Network, Toronto · Tests: Image-guided Radiotherapy Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial NCT06496256NA13 sites📍 Chandler📍 Santa Barbara📍 Boca Raton Palette Life Sciences, Inc. · Tests: Barrigel, Transrectal Ultrasound Salvage HDR for Locally Recurrent Prostate Cancer NCT04231006NA1 site📍 Aarhus Aarhus University Hospital · Tests: High dose rate brachytherapy Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer NCT07667400Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: SX-682, DTX Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer NCT07860047Phase 24 sites📍 Heidelberg📍 Tübingen📍 Berlin University Hospital Tuebingen · Tests: PSMAxCD3, bispecific antibody CC-1, Multipeptide Vaccine VAC-XS15-PC01 Long-term Better Than Short-term ADT With Salvage RT NCT04242017Phase 2, Phase 33 sites📍 Ghent📍 Ghent📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: Triptoreline Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer NCT07500701Phase 31 site📍 Seoul Samsung Medical Center · Tests: Moderate hypofractionated radiotherapy (Moderate-hypoRT), Ultra-hypofractionated radiotherapy (Ultra-hypoRT) PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores NCT03495427Phase 2, Phase 31 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: F-DCFPyL Injection, PSMA PET Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial NCT07466498Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Androgen Receptor Pathway Inhibitor, Transdermal Estrogen, Bone Scan, Computed Tomography, Dual X-ray Absorptiometry Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors NCT05283330Phase 18 sites📍 Chicago📍 Iowa City📍 Lexington Orano Med Theranostics, SAS · Tests: ²¹²Pb-DOTAM-GRPR1 PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer NCT07234981Phase 21 site📍 Omaha University of Nebraska · Tests: PSMA-guided Salvage Radiation Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer NCT04794777Phase 35 sites📍 Gothenburg📍 Stockholm📍 Stockholm Stefan Carlsson · Tests: Individualised therapy, Standard salvage therapy Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging NCT04423211Phase 3341 sites📍 Anchorage📍 Anchorage📍 Anchorage ECOG-ACRIN Cancer Research Group · Tests: 3-Dimensional Conformal Radiation Therapy, Apalutamide, Computed Tomography, Degarelix, External Beam Radiation Therapy Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era NCT06508567NA1 site📍 Toronto University Health Network, Toronto · Tests: High Dose Rate Brachytherapy PSMA-Guided Surgery and Tissue-Resident T-Cell Profiling in Node-Positive Prostate Cancer NCT07879820NA1 site📍 Milan Niguarda Hospital · Tests: PSMA-Radioguided Robot-Assisted Radical Prostatectomy With Extended Pelvic Lymph-Node Dissection PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy NCT04642027Phase 313 sites📍 Arnhem📍 Nijmegen📍 Maastricht University Medical Center Groningen · Tests: Conventional sEBRT, Hypofractionated sEBRT Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. NCT06046131NA2 sites📍 Rennes📍 Pointe-à-Pitre Centre Hospitalier Universitaire de la Guadeloupe · Tests: Standard care Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial NCT07650240Phase 21 site📍 Rochester Mayo Clinic · Tests: Abiraterone Acetate, Biospecimen Collection, Leuprolide Acetate, Lutetium Lu 177 Vipivotide Tetraxetan, Prednisone PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer NCT04700332Phase 21 site📍 Irvine Hoag Memorial Hospital Presbyterian · Tests: DCFPyL PET/CT Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial NCT07202247Phase 21 site📍 Duarte City of Hope Medical Center · Tests: Antiandrogen Therapy, Behavioral Intervention, Biospecimen Collection, Cardiac Computerized Tomographic Angiography, Co… Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro) NCT07365423Phase 211 sites📍 Baden📍 Basel📍 Bellinzona Swiss Cancer Institute · Tests: Terbinafine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy